DK1499312T3 - Anvendelse af hydroxypyridonderivater til sårheling - Google Patents

Anvendelse af hydroxypyridonderivater til sårheling

Info

Publication number
DK1499312T3
DK1499312T3 DK03718739T DK03718739T DK1499312T3 DK 1499312 T3 DK1499312 T3 DK 1499312T3 DK 03718739 T DK03718739 T DK 03718739T DK 03718739 T DK03718739 T DK 03718739T DK 1499312 T3 DK1499312 T3 DK 1499312T3
Authority
DK
Denmark
Prior art keywords
wound healing
hydroxypyridone derivatives
hydroxypyridone
derivatives
wounds
Prior art date
Application number
DK03718739T
Other languages
English (en)
Inventor
Karl Theodor Kraemer
Manfred Bohn
Roland H Wenger
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1499312T3 publication Critical patent/DK1499312T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
DK03718739T 2002-04-20 2003-04-08 Anvendelse af hydroxypyridonderivater til sårheling DK1499312T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02008902A EP1354586A1 (en) 2002-04-20 2002-04-20 The use of hydroxpyridone-derivatives in wound healing
PCT/EP2003/003618 WO2003088966A1 (en) 2002-04-20 2003-04-08 The use of hydroxypyridone-derivatives in wound healing

Publications (1)

Publication Number Publication Date
DK1499312T3 true DK1499312T3 (da) 2007-07-02

Family

ID=28459510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03718739T DK1499312T3 (da) 2002-04-20 2003-04-08 Anvendelse af hydroxypyridonderivater til sårheling

Country Status (16)

Country Link
US (1) US20040014794A1 (da)
EP (2) EP1354586A1 (da)
JP (1) JP4709489B2 (da)
AT (1) ATE357915T1 (da)
AU (1) AU2003222802B2 (da)
BR (1) BR0309403A (da)
CA (1) CA2482972C (da)
CY (1) CY1106472T1 (da)
DE (1) DE60312840T2 (da)
DK (1) DK1499312T3 (da)
ES (1) ES2282615T3 (da)
IL (1) IL164536A (da)
MX (1) MXPA04009186A (da)
PT (1) PT1499312E (da)
SI (1) SI1499312T1 (da)
WO (1) WO2003088966A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009044403A2 (en) 2007-10-05 2009-04-09 Juvenis Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
WO2011153197A1 (en) 2010-06-01 2011-12-08 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
GB201509847D0 (en) * 2015-06-08 2015-07-22 Nautilus Biosciences Canada Inc Anti-dandruff agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322169C (en) * 1988-04-22 1993-09-14 Hiroshi Yamazaki Ionic dressing of topical administration of drugs to wounds and burns
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US5728546A (en) * 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
ATE230389T1 (de) * 1995-10-25 2003-01-15 Senju Pharma Co Angiogenese inhibitoren
US5811078A (en) * 1997-03-14 1998-09-22 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith
DE19802708A1 (de) * 1998-01-24 1999-07-29 Hoechst Marion Roussel De Gmbh Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
US7387779B2 (en) * 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
SE521431C2 (sv) * 1999-12-02 2003-11-04 Sca Hygiene Prod Ab Användning av en pH-buffrande substans för att förhindra hudinfektioner orsakade av Candida Albicans
WO2002077199A2 (en) * 2001-03-27 2002-10-03 Massachusetts Institute Of Technology Methods and products related to fgf dimerization
WO2003018014A2 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives

Also Published As

Publication number Publication date
US20040014794A1 (en) 2004-01-22
SI1499312T1 (sl) 2007-08-31
AU2003222802B2 (en) 2008-01-03
CA2482972C (en) 2011-02-01
ATE357915T1 (de) 2007-04-15
AU2003222802A1 (en) 2003-11-03
DE60312840T2 (de) 2007-12-13
IL164536A0 (en) 2005-12-18
EP1499312B1 (en) 2007-03-28
WO2003088966A1 (en) 2003-10-30
JP4709489B2 (ja) 2011-06-22
CA2482972A1 (en) 2003-10-30
IL164536A (en) 2011-11-30
CY1106472T1 (el) 2012-01-25
BR0309403A (pt) 2005-02-01
PT1499312E (pt) 2007-05-31
DE60312840D1 (de) 2007-05-10
EP1499312A1 (en) 2005-01-26
EP1354586A1 (en) 2003-10-22
ES2282615T3 (es) 2007-10-16
JP2005529875A (ja) 2005-10-06
MXPA04009186A (es) 2004-11-26

Similar Documents

Publication Publication Date Title
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ATE385419T1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
DK1864975T3 (da) Nikotinamid-derivater anvendelige som P38-inhibitorer
EA200600317A1 (ru) Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты)
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
ATE408601T1 (de) Fredericamycin-derivate
ATE302775T1 (de) Carbolinderivate
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
DE60324544D1 (de) Muskarin antagonisten
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
ATE346067T1 (de) Carbolinderivate
DE60121461D1 (de) Kondensierte pyridoindolderivate
SE0400043D0 (sv) New compounds
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DK1499312T3 (da) Anvendelse af hydroxypyridonderivater til sårheling
DK1441726T3 (da) Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorer
BR0206922A (pt) Compostos orgânicos
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung